Metabolism Flashcards
(125 cards)
What are Inborn Metabolic Diseases?
·Individually rare, collectively a significant health problem
·Approx 1:1-2,000 live births
·25-50 in Yorkshire p.a.
·Most present in childhood
Mechanisms of metabolic Disease
Mechanisms of metabolic Disease
What is a consequences of urea cycle defects?
Ammonia accumulates in patients with urea cycle defects
Clinical effects of acute hyperammonaemia toxicity - lethargy -poor feeding - vomiting - tachypnoea - convulsions - coma - death Hyperammonaemia is a medical emergency and must be acted upon immediately
What are possible signs of photosensitive porphyria?
Sensitivity to the sun/artificial light
- Sudden painful erythema and oedema
- Blisters that take weeks to heal
- Itching
- Fragile skin
- Increased hair growth
- Red or brown urine
What are possible signs of acute porphyria?
Severe abdominal pain
- Pain in your chest, legs or back
- Constipation or diarrhoea
- Vomiting
- Insomnia
- Heartbeat you can feel (palpitations)
- High blood pressure
- Anxiety or restlessness
- Seizures
- Mental changes
- Breathing problems
- Muscle pain/tingling/weakness/paralysis
- Red or brown urine
What happens in porphyrias?
Porphyrins accumulate in the porphyrias
What can energy defieciecy cause?
Energy deficiency causes crisis presentations in defects of fatty acid oxidation
What is androgen insensitivity syndrome?
an occur due to defective receptors
·healthy female phenotype normal breast development absent pubic hair, genetic male
·partial defect results in ambiguous genitalia
·presentation: primary amenorrhoea, infertility
·usually need surgical resection of residual gonads
What is Clinical Heterogeneity?
·Genetic variability of lesions, most disorders are multi-allelic
·Variability of other aspects / components of metabolism
·Environment
most patients are compound heterozygotes
Often genotype/phenotype correlation is poor – patients with AIS can have different presentations within the same family (with same mutations)
How are IEM diagnosed?
·Pre-symptomatic screening
·whole population
·selected groups
·Investigation of symptomatic individuals
·test body fluids for abnormal metabolites
·measure enzyme activities
·histochemical / immunochemical staining
·DNA analysis
Investigation of symptomatic patients
·Disorders are genetic why not genes 1st?
- cost/time (but both rapidly reducing with next generation sequencing (NGS))
- ?completely exclude disorders, not all mutations maybe covered (+large deletions etc)
- significance of mutation not always known, often poor genotype phenotype relationship
·
·But this is evolving (the “omics” era)
- genomics (whole exome sequencing (WES), whole genome sequencing)
- metabolomics
What is tested in a basic urine metabolic screen?
Spot tests Organic acids Amino acids Sugar Chromatography Oligosaccharides/Sialic Acids Mucopolysaccharides
What are classic organic acidaemias?
classic organic acidaemias: propionic, isovaleric, methyl malonic acidaemia]
Defects in branched chain AA catabolism
What are pre-natal screening tests for neural tube defects?
·maternal serum and amniotic fluid AFP
·ultrasound scan at 16 weeks
What are pre-natal screening tests for Downs syndrome defects?
·1st trimester; PAPA, HCG and nuchal translucency
·2nd trimester, maternal serum AFP HCG, inhibin and estriol
·Test on the ascent: free fetal DNA
What is screening?
Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and/or treatment to reduce their risk and/or complications.
Screening is never 100% sensitive or specific (i.e. false positives and negatives)
What is the Wilson and Jungner Criteria?
principles for screening
·Disease must be sufficiently common
·Natural history must be known
·Early therapeutic intervention beneficial
·Acceptable and affordable screening test
·Diagnostic confirmatory test
Newborn Screening in the UK
·All babies tested at 5d (5-8 exceptional)
·Most samples taken in community by midwives
·Regional laboratories perform tests and report results
·Standards set by The UK Newborn Screening Programme Centre
·Nature of the programme defined by The National Screening Committee
Screened for: ·PKU, Congenital hypothyroidism, Sickle cell and Hb disorders, CF, MCADD, MSUD, IVA, Homocystinuria – non-pyridoxine responsive, GA1
What is Phenylketonuria?
·Affects 1: 10,000 Caucasian births
increased phenylalanine due to lack of enzymes
·Severe intellectual disability·seizures, tremors, spasticity, behavioural problems, irritability, eczema in childhood if untreated
·Excellent prognosis if treated from birth
·Screening test: bloodspot phenylalanine
On examination child may be ·Sitting with support, not vocalising, or reaching out or picking up objects, Not startled by noise, ? Not recognising parents, brief episodes of shaking and eye rolling
·Confirm diagnosis with plasma phenylalanine measurements
·no need to measure enzyme or DNA
What is the treatment of Phenylketonuria?
·Low phenylalanine diet
·Requires careful monitoring
·Risk tyrosine insufficiency
·Risk vitamin and trace element deficiencies
·?biopterin supplementation (saproterin)
·Large Neutral Amino Acids (val, leu, ileu)
What is the prognosis of Phenylketonuria?
Eventual IQ outcome correlates with blood phe
Pathophysiological determinant likely to be brain phe
·Neurological damage not reversible
Eventual IQ outcome correlates with blood phe
Pathophysiological determinant likely to be brain phe
·Neurological damage not reversible
·Affects 1: 1,500 UK births
·Severe developmental delay if untreated
·Excellent prognosis if treated from birth
·Screening test: bloodspot TSH
·Confirm diagnosis with plasma thyroid function tests
·no need to measure enzyme or DNA
·Treatment with thyroxine, carefully monitored
What is Cystic Fibrosis?
·Most common inherited, 1:2,500
·Most controversial
·Not all cases detected by IRT-DNA protocol
·Doubts about clinical benefits of early treatment
·Identification of less severe variants
·Identification of heterozygotes
What are Haemoglobinopathies?
·Early detection and treatment of sickle cell disease
·Sickle disease affects 1:2000 babies (up to 1 in 300)
·Also detect carriers and compound heterozygotes with HbC/DPunjab/E/OArab/β-thal
·β-thalassaemia major detected
·Linked to the antenatal haemoglobinopathy screening programme